Bruton tyrosine kinase (BTK) inhibitors have become a mainstay of treatment for relapsed or refractory (R/R) mantle cell ...
Lilly opens early access to retatrutide for some patients before FDA approval, following scrutiny over a single earlier compassionate-use case. A source familiar with Lilly's program told STAT that ...
Prior authorization, coverage limits, and affordability screening increasingly determine when CAR T or bispecifics are ...
Rising summer temperatures and prolonged UV exposure can accelerate the breakdown of larger plastics into these microscopic particles, increasing opportunities for human exposure, ...
UPMC and Birth Root Community Doula describe a 4-year partnership addressing food insecurity, housing, and maternal health ...
Anosheh Afghahi, MD, discusses biomarker testing, trial matching technology, and community-academic partnerships to improve ...
In this study, 13% of patients who stopped heart failure medications after successful AF ablation had HF deterioration vs none who continued treatment. A single-center study found low rates of MRA and ...
CTGTAC concluded the evidentiary package did not substantiate clinical benefit for DMD cardiomyopathy, with multiple members characterizing the efficacy findings as statistically and clinically ...
Young adults with sarcoma face challenges that extend well beyond treatment, and closing gaps in research funding and specialty care could improve outcomes for this population and beyond, according to ...
Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review. Legal compounding remains ...
Indication expansion enables PSMA-targeted radioligand therapy earlier in metastatic prostate cancer, pairing Pluvicto with ARP inhibition plus ADT/orchiectomy for androgen pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results